| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Monday - Mar 04, 2024 |
|||||||||
|
Crescent Energy
CRGY
|
- | $0.61 | $0.15 | $657.73M | $580.88M |
NYSE |
|||
|
Stitch Fix
SFIX
|
Q2 FY24 | -$0.21 | -$0.21 | $330.40M | $330.85M |
NASDAQ |
|||
|
Crawford &
CRD-A
|
- | $0.06 | $0.12 | $320.93M | $309.46M |
NYSE |
|||
|
Atlanticus Holdings
ATLC
|
- | $1.06 | $0.96 | $309.09M | $306.48M |
NASDAQ |
|||
|
Southland Holdings
SLND
|
- | -$0.12 | -$0.02 | $316.19M | $274.35M |
AMEX |
|||
|
INNOVATE
VATE
|
Q4 FY23 | -$1.20 | - | $361M | $248.10M |
NYSE |
|||
|
Commercial Vehicle Group
CVGI
|
- | $0.09 | $0.15 | $223.09M | $248.01M |
NASDAQ |
|||
|
Paymentus Holdings
PAY
|
Q4 FY23 | $0.11 | $0.06 | $164.80M | $181.08M |
NYSE |
|||
AeroVironment
AVAV
|
Q3 FY24 | $0.63 | $0.33 | $186.58M | $170.62M |
NASDAQ |
|||
|
GitLab
GTLB
|
Q4 FY24 | $0.15 | $0.08 | $163.78M | $165.89M |
NASDAQ |
|||
|
Ranger Energy Services
RNGR
|
- | $0.09 | $0.29 | $151.50M | $151M |
NYSE |
|||
|
Northwest Pipe
NWPX
|
- | $0.54 | $0.42 | $110.26M | $103.34M |
NASDAQ |
|||
|
Semrush Holdings
SEMR
|
- | $0.08 | $0.04 | $83.39M | $86.25M |
NYSE |
|||
ThredUp
TDUP
|
Q4 FY23 | -$0.14 | -$0.13 | $81.39M | $80.33M |
NASDAQ |
|||
|
Viant Technology
DSP
|
Q4 FY23 | $0.14 | $0.11 | $64.41M | $65.92M |
NASDAQ |
|||
|
Stellus Capital Investment
SCM
|
- | $0.49 | $0.45 | $9.94M | $27.47M |
NYSE |
|||
|
Akoya Biosciences
AKYA
|
Q4 FY23 | -$0.22 | -$0.27 | $26.49M | $25.89M |
NASDAQ |
|||
|
ICC Holdings
ICCH
|
- | $1.03 | - | $22.91M | - |
NASDAQ |
|||
|
Nektar Therapeutics
NKTR
|
Q4 FY23 | -$0.22 | -$0.20 | $23.89M | $18.05M |
NASDAQ |
|||
|
OFS Capital
OFS
|
- | $0.35 | $0.39 | $13.48M | $14.50M |
NASDAQ |
|||
|
LENSAR
LNSR
|
Q4 FY23 | -$0.35 | -$0.22 | $12.11M | $12M |
NASDAQ |
|||
|
Eos Energy Enterprises
EOSE
|
- | -$0.16 | -$0.22 | $6.61M | $12M |
NASDAQ |
|||
|
Cara Therapeutics
CARA
|
Q4 FY23 | -$7.08 | -$6.84 | $3M | $9.42M |
NASDAQ |
|||
|
Stereotaxis
STXS
|
Q4 FY23 | -$0.07 | -$0.07 | $4.57M | $7.70M |
AMEX |
|||
|
Passage Bio
PASG
|
- | -$0.30 | -$0.41 | $5.91M | - |
NASDAQ |
|||
|
Ekso Bionics Holdings
EKSO
|
Q4 FY23 | -$0.22 | -$0.11 | $4.85M | $4.77M |
NASDAQ |
|||
|
Jasper Therapeutics
JSPR
|
- | -$1.50 | -$1.65 | $2.05M | - |
NASDAQ |
|||
|
Astria Therapeutics
ATXS
|
- | -$0.86 | -$0.69 | - | - |
NASDAQ |
|||
| Show 18 more companies | |||||||||
